Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron)
23 mars 2020 06h00 HE
|
Helsinn Healthcare S.A.
Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron) Lugano, Switzerland, March 23, 2020 – Helsinn, the Swiss pharmaceutical group focused on building...